|
US2527861A
(en)
*
|
1948-05-07 |
1950-10-31 |
Monsanto Chemicals |
Mono alkyl sulfamides
|
|
BE636655A
(https=)
*
|
1962-09-14 |
|
|
|
|
DE1211166B
(de)
|
1962-11-20 |
1966-02-24 |
Ciba Geigy |
Verfahren zur Herstellung neuer Sulfamide
|
|
US3318952A
(en)
*
|
1964-01-22 |
1967-05-09 |
Sandoz Ag |
Dibenzylsulfamides
|
|
US3320314A
(en)
|
1964-01-22 |
1967-05-16 |
Sandoz Ag |
Chlorobenzyl sulfamides
|
|
US3383414A
(en)
*
|
1964-08-26 |
1968-05-14 |
Sandoz Ag |
Benzocycloalkyl sulfamides
|
|
DE1542785A1
(de)
|
1965-07-24 |
1970-05-06 |
Bayer Ag |
Insekten- und milbenabweisende Mittel
|
|
US3539573A
(en)
|
1967-03-22 |
1970-11-10 |
Jean Schmutz |
11-basic substituted dibenzodiazepines and dibenzothiazepines
|
|
US3621096A
(en)
*
|
1969-04-03 |
1971-11-16 |
Univ North Carolina |
Antidepressant method and composition for same comprising a tricyclic antidepressant and a thyroid hormone
|
|
DE2022370A1
(de)
|
1970-05-08 |
1971-12-02 |
Bayer Ag |
N-Fluordichlormethylthio-sulfamidsaeure-Derivate,Verfahren zu ihrer Herstellung und ihre mikrobizide und fungizide Verwendung
|
|
US5212326A
(en)
|
1979-08-20 |
1993-05-18 |
Abbott Laboratories |
Sodium hydrogen divalproate oligomer
|
|
FR2479825A1
(fr)
*
|
1980-04-04 |
1981-10-09 |
Fabre Sa Pierre |
Benzodioxanne 1,4 methoxy-2 propanolamines, leur preparation et leur application en tant que medicaments
|
|
US4513006A
(en)
|
1983-09-26 |
1985-04-23 |
Mcneil Lab., Inc. |
Anticonvulsant sulfamate derivatives
|
|
US4804663A
(en)
|
1985-03-27 |
1989-02-14 |
Janssen Pharmaceutica N.V. |
3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
|
|
IE58370B1
(en)
*
|
1985-04-10 |
1993-09-08 |
Lundbeck & Co As H |
Indole derivatives
|
|
GB8607684D0
(en)
|
1986-03-27 |
1986-04-30 |
Ici America Inc |
Thiazepine compounds
|
|
US4831031A
(en)
|
1988-01-22 |
1989-05-16 |
Pfizer Inc. |
Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
|
|
US5158952A
(en)
*
|
1988-11-07 |
1992-10-27 |
Janssen Pharmaceutica N.V. |
3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
|
|
US5238945A
(en)
*
|
1989-04-11 |
1993-08-24 |
H. Lundbeck A/S |
Method of treating psychoses
|
|
GB8908085D0
(en)
|
1989-04-11 |
1989-05-24 |
Lundbeck & Co As H |
New therapeutic use
|
|
US5194446A
(en)
*
|
1989-06-12 |
1993-03-16 |
A. H. Robins Company, Incorporated |
Compounds having one or more aminosulfaonyloxy radicals useful as pharmaceuticals
|
|
US5273993A
(en)
*
|
1989-06-12 |
1993-12-28 |
A. H. Robins Company, Incorporated |
Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals
|
|
US5192785A
(en)
*
|
1989-09-03 |
1993-03-09 |
A. H. Robins Company, Incorporated |
Sulfamates as antiglaucoma agents
|
|
US5229382A
(en)
|
1990-04-25 |
1993-07-20 |
Lilly Industries Limited |
2-methyl-thieno-benzodiazepine
|
|
US5189179A
(en)
|
1990-08-29 |
1993-02-23 |
Merrell Dow Pharmaceuticals Inc. |
Serotonin 5ht1a agonists
|
|
AU641052B2
(en)
|
1990-11-02 |
1993-09-09 |
Aventisub Ii Inc. |
3-amidoindolyl derivatives
|
|
GB9026998D0
(en)
|
1990-12-12 |
1991-01-30 |
Glaxo Group Ltd |
Medicaments
|
|
US5120758A
(en)
|
1991-02-08 |
1992-06-09 |
Ciba-Geigy Corporation |
Certain benzodioxole, benzodioxane and benzodioxepin derivatives useful as 5-lipoxygenase inhibitors
|
|
GB9104890D0
(en)
|
1991-03-08 |
1991-04-24 |
Glaxo Group Ltd |
Compositions
|
|
IL103172A
(en)
*
|
1991-09-19 |
1997-01-10 |
Mcneilab Inc |
Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol
|
|
US5242942A
(en)
|
1992-04-28 |
1993-09-07 |
Mcneilab, Inc. |
Anticonvulsant fructopyranose cyclic sulfites and sulfates
|
|
US5258402A
(en)
*
|
1992-06-11 |
1993-11-02 |
Mcneil-Ppc, Inc. |
Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
|
|
US5312925A
(en)
|
1992-09-01 |
1994-05-17 |
Pfizer Inc. |
Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride
|
|
US5384327A
(en)
|
1992-12-22 |
1995-01-24 |
Mcneilab, Inc. |
Anticonvulsant sorbopyranose sulfamates
|
|
CA2179733C
(en)
|
1993-12-23 |
2007-03-27 |
Michael J. Costanzo |
Anticonvulsant pseudofructopyranose sulfamates
|
|
GB9417532D0
(en)
|
1994-08-31 |
1994-10-19 |
Zeneca Ltd |
Aromatic compounds
|
|
JPH11501619A
(ja)
*
|
1995-02-15 |
1999-02-09 |
ベアーズデン バイオ，インコーポレイテッド |
アルキルカルボキシアミノ酸−カイネートレセプターのモジュレーター
|
|
JP3235448B2
(ja)
*
|
1995-03-24 |
2001-12-04 |
ダイソー株式会社 |
１，４−ベンゾジオキサン誘導体の製法
|
|
US5998380A
(en)
*
|
1995-10-13 |
1999-12-07 |
New England Medical Center Hospitals, Inc. |
Treatment of migraine
|
|
AU7655796A
(en)
|
1995-11-30 |
1997-06-19 |
C & C Research Laboratories |
Sulfamide derivatives
|
|
AU1328197A
(en)
|
1995-12-01 |
1997-06-19 |
Synaptic Pharmaceutical Corporation |
Aryl sulfonamide and sulfamide derivatives and uses thereof
|
|
EP0906104A4
(en)
|
1996-03-25 |
2003-12-10 |
Lilly Co Eli |
PAIN TREATMENT PROCESS
|
|
RU2214241C2
(ru)
*
|
1996-06-28 |
2003-10-20 |
Орто-Макнейл Фармасьютикал, Инк. |
Способ лечения ожирения и способ индуцирования потери веса у млекопитающих
|
|
US5753693A
(en)
|
1996-06-28 |
1998-05-19 |
Ortho Pharmaceutical Corporation |
Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder
|
|
WO1998000124A1
(en)
|
1996-06-28 |
1998-01-08 |
Ortho Pharmaceutical Corporation |
Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of postischemic neurodegeneration
|
|
US5753694A
(en)
|
1996-06-28 |
1998-05-19 |
Ortho Pharmaceutical Corporation |
Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (ALS)
|
|
CZ297679B6
(cs)
|
1996-08-14 |
2007-03-07 |
G. D. Searle & Co. |
Krystalická forma B 4-[5-methyl-3-fenylizoxazol-4-yl]benzensulfonamidu
|
|
WO1998007447A1
(en)
*
|
1996-08-23 |
1998-02-26 |
Algos Pharmaceutical Corporation |
Anticonvulsant containing composition for treating neuropathic pain
|
|
CA2267945C
(en)
|
1996-10-08 |
2005-05-17 |
Ortho-Mcneil Pharmaceutical, Inc. |
Anticonvulsant derivatives useful in treating neuropathic pain
|
|
US20020015713A1
(en)
*
|
1996-10-24 |
2002-02-07 |
Murdock Robert W. |
Methods and transdermal compositions for pain relief
|
|
US5760007A
(en)
*
|
1997-07-16 |
1998-06-02 |
Ortho Pharmaceutical Corporation |
Anticonvulsant derivatives useful in treating neuropathic pain
|
|
US5935933A
(en)
*
|
1997-07-16 |
1999-08-10 |
Ortho-Mcneil Pharmaceutical, Inc. |
Anticonvulsant derivatives useful in treating neuropathic pain
|
|
EP1014959B1
(en)
*
|
1997-08-15 |
2004-10-20 |
Carolyn Ann Fairbanks |
Agmatine as a treatment for neuropathic pain
|
|
GB9803536D0
(en)
|
1998-02-19 |
1998-04-15 |
Black James Foundation |
Histamine H,receptor ligands
|
|
UA65607C2
(uk)
|
1998-03-04 |
2004-04-15 |
Орто-Макнейл Фармацевтикал, Інк. |
Фармацевтична композиція (варіанти) та спосіб її приготування
|
|
DK72798A
(da)
|
1998-05-28 |
1998-05-28 |
Novo Nordisk As |
Treatment of GABA-uptake related disorders
|
|
BR9911068A
(pt)
|
1998-05-29 |
2001-02-06 |
Lilly Co Eli |
Terapia combinada para tratamento de distúrbios bipolares
|
|
WO2000001376A2
(en)
|
1998-07-02 |
2000-01-13 |
Eisai Co., Ltd |
Pharmaceutical compositions and their uses for treatment of demyelinating disorders
|
|
US6541520B1
(en)
|
1998-08-05 |
2003-04-01 |
Brookhaven Science Associates |
Treatment of addiction and addiction-related behavior
|
|
ATE279921T1
(de)
*
|
1999-01-19 |
2004-11-15 |
Ortho Mcneil Pharm Inc |
Verwendung von antikonvulsiven derivaten zur behandlung der cluster headache
|
|
WO2000042995A2
(en)
|
1999-01-21 |
2000-07-27 |
Ortho-Mcneil Pharmaceutical, Inc. |
Use of anticonvulsant derivatives for treating transformed migraine
|
|
GB9903784D0
(en)
|
1999-02-18 |
1999-04-14 |
Lilly Co Eli |
Pharmaceutical compounds
|
|
ATE294577T1
(de)
*
|
1999-02-24 |
2005-05-15 |
Univ Cincinnati |
Verwendung von sulfamat derivaten zur behandlung von impulsiven störungen
|
|
EP1124416A1
(en)
|
1999-03-15 |
2001-08-22 |
John Claude Krusz |
Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages
|
|
NZ514811A
(en)
|
1999-04-08 |
2005-01-28 |
Ortho Mcneil Pharm Inc |
Anticonvulsant derivatives useful in reducing blood glucose levels
|
|
WO2000061138A1
(en)
*
|
1999-04-08 |
2000-10-19 |
Ortho-Mcneil Pharmaceutical, Inc. |
Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
|
|
US6191163B1
(en)
*
|
1999-04-08 |
2001-02-20 |
Ortho-Mcneil Pharmaceutical, Inc. |
Anticonvulsant derivatives useful in lowering lipids
|
|
WO2000061140A1
(en)
|
1999-04-08 |
2000-10-19 |
Ortho-Mcneil Pharmaceutical, Inc. |
Anticonvulsant derivatives useful in maintaining weight loss
|
|
DK1181012T3
(da)
|
1999-05-04 |
2005-01-24 |
Keith R Edwards |
Intravenöst valproat til akut behandling af migrænehovedpine
|
|
WO2000076493A1
(en)
|
1999-06-14 |
2000-12-21 |
Thomas Najarian |
Combination therapy for effecting weight loss and treating obesity
|
|
PL213323B1
(pl)
|
1999-08-20 |
2013-02-28 |
Ortho Mcneil Pharm Inc |
Kompozycja farmaceutyczna i jej zastosowanie
|
|
FR2803848B1
(fr)
|
2000-01-19 |
2002-02-15 |
Adir |
Nouveaux derives de benzenesulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US6322503B1
(en)
*
|
2000-02-17 |
2001-11-27 |
G. Roger Sparhawk, Jr. |
Method of diagnosing, tracking, and treating depression
|
|
US20010036943A1
(en)
|
2000-04-07 |
2001-11-01 |
Coe Jotham W. |
Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
|
|
CA2415093A1
(en)
|
2000-07-07 |
2002-01-17 |
Carlos Plata-Salaman |
Anticonvulsant derivatives useful for preventing the development of type ii diabetes mellitus and syndrome x
|
|
DE10035227A1
(de)
|
2000-07-20 |
2002-01-31 |
Solvay Pharm Gmbh |
Verfahren zum Auffinden von Verbindungen, welche zur Behandlung und/oder Prophylaxe von Fettleibigkeit geeignet sind
|
|
EP1309325A1
(en)
*
|
2000-08-02 |
2003-05-14 |
Ortho-McNeil Pharmaceutical, Inc. |
Anticonvulsant derivatives useful for the treatment of depression
|
|
PE20021046A1
(es)
|
2000-09-30 |
2002-12-14 |
Gruenenthal Chemie |
Sulfonilguanidina que tiene afinidad al punto de fijacion de gabapentina
|
|
US7256184B2
(en)
*
|
2000-10-16 |
2007-08-14 |
Rodriguez Victorio C |
Treatment of aging disorders in humans
|
|
EP1357908A4
(en)
*
|
2001-01-30 |
2009-07-15 |
Merck & Co Inc |
"ACYLSULFAMIDES FOR THE TREATMENT OF FATIBILITY, DIABETES AND LIPID DISORDERS"
|
|
WO2002089785A1
(en)
|
2001-05-07 |
2002-11-14 |
Smithkline Beecham Corporation |
Sulfonamides
|
|
JP2004536071A
(ja)
|
2001-05-25 |
2004-12-02 |
クイーンズ ユニバーシティ アット キングストン |
複素環ベータアミノ酸およびそれらの抗癲癇誘発剤としての使用
|
|
US20030100594A1
(en)
|
2001-08-10 |
2003-05-29 |
Pharmacia Corporation |
Carbonic anhydrase inhibitor
|
|
US6559293B1
(en)
*
|
2002-02-15 |
2003-05-06 |
Transform Pharmaceuticals, Inc. |
Topiramate sodium trihydrate
|
|
US8637512B2
(en)
*
|
2002-07-29 |
2014-01-28 |
Glaxo Group Limited |
Formulations and method of treatment
|
|
RU2226357C1
(ru)
|
2003-02-12 |
2004-04-10 |
Санкт-Петербургский научно-исследовательский психоневрологический институт им. В.М.Бехтерева |
Способ диагностики эпилепсии у пациентов с доклинической стадией болезни
|
|
RU2246727C2
(ru)
|
2003-02-12 |
2005-02-20 |
Санкт-Петербургский научно-исследовательский психоневрологический институт им. В.М. Бехтерева (НИПИ) |
Способ диагностики доклинической стадии эпилепсии
|
|
US7425631B2
(en)
|
2003-04-10 |
2008-09-16 |
Amgen Inc. |
Compounds and methods of use
|
|
EP1615629B1
(en)
|
2003-04-16 |
2009-03-18 |
Smithkline Beecham Corporation |
Peptide deformylase inhibitors
|
|
WO2004093912A1
(ja)
|
2003-04-23 |
2004-11-04 |
Kyowa Hakko Kogyo Co. Ltd. |
好中球性炎症疾患の予防および／または治療剤
|
|
GB0309781D0
(en)
|
2003-04-29 |
2003-06-04 |
Glaxo Group Ltd |
Compounds
|
|
US6949518B1
(en)
*
|
2003-06-25 |
2005-09-27 |
Pao-Hsien Chu |
Methods for treating macular degeneration with topiramate
|
|
CN1845914A
(zh)
|
2003-09-02 |
2006-10-11 |
默克公司 |
用于治疗眼压过高的眼用组合物
|
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
|
MY147767A
(en)
|
2004-06-16 |
2013-01-31 |
Janssen Pharmaceutica Nv |
Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
|
|
AR049646A1
(es)
|
2004-06-16 |
2006-08-23 |
Janssen Pharmaceutica Nv |
Derivados de sulfamato y sulfamida utiles para el tratamiento de la epilepsia y trastornos relacionados
|
|
US7569604B2
(en)
|
2004-06-22 |
2009-08-04 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives for modulation of calcium channels
|
|
KR101261305B1
(ko)
|
2004-07-28 |
2013-05-08 |
얀센 파마슈티카 엔.브이. |
히스톤 디아세틸라제의 신규한 저해제로의 치환된 인돌릴알킬 아미노 유도체
|
|
US20060276528A1
(en)
*
|
2004-08-24 |
2006-12-07 |
Abdel-Magid Ahmed F |
Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
|
|
DE602005008084D1
(de)
|
2004-08-24 |
2008-08-21 |
Janssen Pharmaceutica Nv |
Als antikonvulsive mittel geeignete neue benzokondensierte heteroarylsulfamidderivate
|
|
CA2605580A1
(en)
*
|
2005-04-22 |
2006-11-02 |
Wyeth |
Benzodioxane and benzodioxolane derivatives and uses thereof
|
|
KR20080012360A
(ko)
*
|
2005-05-20 |
2008-02-11 |
얀센 파마슈티카 엔.브이. |
설파미드 유도체의 제조 방법
|
|
US20070155823A1
(en)
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
|
|
US20070155824A1
(en)
*
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesis
|
|
US20070155827A1
(en)
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
|
|
US8492431B2
(en)
|
2005-12-19 |
2013-07-23 |
Janssen Pharmaceutica, N.V. |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
|
|
US8691867B2
(en)
|
2005-12-19 |
2014-04-08 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
|
|
US8497298B2
(en)
|
2005-12-19 |
2013-07-30 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
|
|
US8716231B2
(en)
|
2005-12-19 |
2014-05-06 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
|
|
US8937096B2
(en)
|
2005-12-19 |
2015-01-20 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
|
|
US20070191474A1
(en)
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
|
|
US20070191452A1
(en)
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of benzo-heteroaryl sulfamide derivatives for the treatment of pain
|
|
TW200738669A
(en)
|
2006-02-22 |
2007-10-16 |
Janssen Pharmaceutica Nv |
Crystalline forms of N-(benzo[b]thien-3-ylmethyl)-sulfamide
|
|
US20070293476A1
(en)
*
|
2006-05-19 |
2007-12-20 |
Smith-Swintosky Virginia L |
Co-therapy for the treatment of epilepsy and related disorders
|
|
EA200870556A1
(ru)
|
2006-05-19 |
2009-06-30 |
Янссен Фармацевтика Н.В. |
Комбинированная терапия в лечении эпилепсии и родственных расстройств
|
|
EP2238122A1
(en)
*
|
2008-01-07 |
2010-10-13 |
Janssen Pharmaceutica, N.V. |
Preparation of sulfamide derivatives
|
|
EA201071121A1
(ru)
|
2008-03-26 |
2011-04-29 |
Янссен Фармацевтика, Н.В. |
Способ получения бензопроизводных диоксина
|
|
KR20100126535A
(ko)
|
2008-03-26 |
2010-12-01 |
얀센 파마슈티카 엔.브이. |
벤조-융합된 헤테로아릴 설파메이트의 제조방법 및 ｎ-(((2ｓ)-6-클로로-2,3-다이하이드로-1,4-벤조다이옥신-2-일)메틸-설파미드의 결정형
|
|
US20090247617A1
(en)
*
|
2008-03-26 |
2009-10-01 |
Abdel-Magid Ahmed F |
Process for the preparation of benzo-fused heteroaryl sulfamates
|
|
US20090247618A1
(en)
*
|
2008-03-26 |
2009-10-01 |
Ballentine Scott A |
Process for preparation of benzo-fused heteroaryl derivatives
|
|
EA018567B1
(ru)
*
|
2008-06-23 |
2013-08-30 |
Янссен Фармацевтика Нв |
Кристаллическая форма (2s)-(-)-n-(6-хлор-2,3-дигидробензо[1,4]диоксин-2-илметил)сульфамида
|
|
US8815939B2
(en)
*
|
2008-07-22 |
2014-08-26 |
Janssen Pharmaceutica Nv |
Substituted sulfamide derivatives
|